Head to Head Comparison: Steris Plc (STE) and Its Competitors
Steris Plc (NYSE: STE) is one of 84 publicly-traded companies in the “Medical Equipment, Supplies & Distribution” industry, but how does it weigh in compared to its rivals? We will compare Steris Plc to similar companies based on the strength of its risk, profitability, institutional ownership, earnings, valuation, analyst recommendations and dividends.
Insider & Institutional Ownership
93.3% of Steris Plc shares are owned by institutional investors. Comparatively, 63.2% of shares of all “Medical Equipment, Supplies & Distribution” companies are owned by institutional investors. 2.6% of Steris Plc shares are owned by company insiders. Comparatively, 13.0% of shares of all “Medical Equipment, Supplies & Distribution” companies are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
This table compares Steris Plc and its rivals’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Steris Plc Competitors||-128.93%||-37.81%||-10.82%|
This is a breakdown of recent recommendations and price targets for Steris Plc and its rivals, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Steris Plc Competitors||323||1483||2597||105||2.55|
Steris Plc currently has a consensus price target of $85.00, suggesting a potential downside of 2.03%. As a group, “Medical Equipment, Supplies & Distribution” companies have a potential upside of 7.01%. Given Steris Plc’s rivals higher probable upside, analysts plainly believe Steris Plc has less favorable growth aspects than its rivals.
Valuation and Earnings
This table compares Steris Plc and its rivals revenue, earnings per share (EPS) and valuation.
|Gross Revenue||EBITDA||Price/Earnings Ratio|
|Steris Plc||$2.58 billion||$521.33 million||61.97|
|Steris Plc Competitors||$827.05 million||$159.46 million||34.48|
Steris Plc has higher revenue and earnings than its rivals. Steris Plc is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.
Steris Plc pays an annual dividend of $1.24 per share and has a dividend yield of 1.4%. Steris Plc pays out 88.6% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. As a group, “Medical Equipment, Supplies & Distribution” companies pay a dividend yield of 0.8% and pay out 37.3% of their earnings in the form of a dividend. Steris Plc has increased its dividend for 7 consecutive years.
Risk and Volatility
Steris Plc has a beta of 1.29, meaning that its stock price is 29% more volatile than the S&P 500. Comparatively, Steris Plc’s rivals have a beta of 1.08, meaning that their average stock price is 8% more volatile than the S&P 500.
Steris Plc beats its rivals on 11 of the 15 factors compared.
Steris Plc Company Profile
STERIS plc provides infection prevention and other procedural products and services. The Company operates through four segments: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance, and installation services, as well as consumables; Healthcare Specialty Services, which provides a range of specialty services for healthcare providers, including hospital sterilization services, instrument and scope repairs, and linen management; Life Sciences, which offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities, and Applied Sterilization Technologies, which offers contract sterilization and laboratory services for medical device and pharmaceutical customers and others. Its Corporate and other segment includes the Defense and Industrial business unit.
Receive News & Ratings for Steris Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris Plc and related companies with MarketBeat.com's FREE daily email newsletter.